Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,058 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Johnson & Johnson Vision Care, Inc. | $389.03 | 2 | $0 (2024) |
| Glaukos Corporation | $267.20 | 2 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $117.97 | 1 | $0 (2023) |
| Allergan, Inc. | $117.57 | 1 | $0 (2020) |
| Dompe US, Inc. | $67.78 | 1 | $0 (2023) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $49.65 | 1 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $48.84 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $69.37 | 1 | Johnson & Johnson Vision Care, Inc. ($69.37) |
| 2023 | $452.95 | 4 | Glaukos Corporation ($267.20) |
| 2022 | $319.66 | 1 | Johnson & Johnson Vision Care, Inc. ($319.66) |
| 2020 | $117.57 | 1 | Allergan, Inc. ($117.57) |
| 2019 | $49.65 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($49.65) |
| 2018 | $48.84 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($48.84) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/12/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $69.37 | General |
| 10/12/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $117.97 | General |
| Category: Ophthalmology | ||||||
| 10/11/2023 | Glaukos Corporation | KXL system (not refurbished) (Device) | Food and Beverage | Cash or cash equivalent | $92.26 | General |
| Category: Corneal Health | ||||||
| 10/10/2023 | Glaukos Corporation | KXL system (not refurbished) (Device) | Food and Beverage | Cash or cash equivalent | $174.94 | General |
| Category: Corneal Health | ||||||
| 06/08/2023 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $67.78 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/11/2022 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $319.66 | General |
| Category: Soft Contact Lenses | ||||||
| 02/25/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $117.57 | General |
| Category: DRY EYE | ||||||
| 10/25/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $49.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/08/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX GEL (Drug), ULTRA MULTIFOCAL TORIC, BIOTRUE | Food and Beverage | In-kind items and services | $48.84 | General |
| Category: OPHTHALMOLOGY | ||||||
About Dr. Andy Chen, O.D
Dr. Andy Chen, O.D is a Low Vision Rehabilitation healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2015. The National Provider Identifier (NPI) number assigned to this provider is 1518348432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andy Chen, O.D has received a total of $1,058 in payments from pharmaceutical and medical device companies, with $69.37 received in 2024. These payments were reported across 9 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,058).
Practice Information
- Specialty Low Vision Rehabilitation
- Other Specialties Low Vision Rehabilitation
- Location Long Beach, CA
- Active Since 06/16/2015
- Last Updated 01/03/2022
- Taxonomy Code 152WL0500X
- Entity Type Individual
- NPI Number 1518348432
Products in Payments
- Acuvue (Device) $319.66
- KXL system (not refurbished) (Device) $267.20
- MIEBO (Drug) $117.97
- RESTASIS (Drug) $117.57
- OXERVATE (Drug) $67.78
- XIIDRA (Drug) $49.65
- LOTEMAX GEL (Drug) $48.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.